China Qinfa Group Limited (0866.HK)
HKD 0.94
(6.82%)
HKD 0.94
(6.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.46 Billion | 984.43 Million | 1.88 Billion | 527.08 Million | 707.86 Million | 568.29 Million |
| Net Income | 352.13 Million | 456.54 Million | 2.79 Billion | -2.9 Billion | 81.42 Million | 1.5 Billion |
| Depreciation & Amortization | 922.7 Million | 963.03 Million | -997.32 Million | 3.46 Billion | 536.38 Million | 380.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 376.42 Million | -222.53 Million | 102.23 Million | -265.49 Million | 195.18 Million | 513.78 Million |
| Other non-cash items | 177.19 Million | -212.61 Million | -10.58 Million | 233.62 Million | -105.12 Million | -1.83 Billion |
| Investing Cash Flow | -1.84 Billion | -835.63 Million | -18.76 Million | -139.67 Million | -330.63 Million | -233.1 Million |
| Investments in PPE | -1.08 Billion | -731.1 Million | -136.7 Million | -122.45 Million | -344.75 Million | -353.95 Million |
| Acquisitions | - | - | -23.64 Million | -34.26 Million | - | -685 Thousand |
| Investment purchases | - | - | -20.11 Million | - | - | - |
| Sales/Maturities of investments | - | 20.55 Million | 43.75 Million | - | - | - |
| Other Investing Activities | -774.61 Million | -125.07 Million | 117.94 Million | 17.04 Million | 14.11 Million | 121.54 Million |
| Financing Cash Flow | -212.07 Million | -307.81 Million | -989.72 Million | -394.07 Million | -332.53 Million | -299.09 Million |
| Debt repayment | -199.91 Million | -949.68 Million | -1.64 Billion | -1.24 Billion | -912.43 Million | -938.86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -12.15 Million | 641.87 Million | 653.8 Million | 855.1 Million | 579.9 Million | 639.76 Million |
| Accounts receivables | 118.16 Million | 2.28 Million | 260.02 Million | -269.31 Million | 192.79 Million | 470.22 Million |
| Accounts payables | - | 249.66 Million | 45.52 Million | 117.3 Million | -75.77 Million | - |
| Inventory | 253.26 Million | -224.82 Million | -157.79 Million | 3.81 Million | 2.38 Million | 43.56 Million |
| Other working capital | -17.28 Million | -249.66 Million | -45.52 Million | -117.3 Million | 75.77 Million | 172.69 Million |
| Cash at beginning of period | 855.99 Million | 1.03 Billion | 154.9 Million | 159.69 Million | 115.68 Million | 80.34 Million |
| Cash at end of period | 302.73 Million | 855.99 Million | 1.03 Billion | 154.9 Million | 159.69 Million | 115.68 Million |
| Capital Expenditure | -1.08 Billion | -731.1 Million | -136.7 Million | -122.45 Million | -344.75 Million | -353.95 Million |
| Effect of forex changes on cash | 41.29 Million | -15.42 Million | -3.84 Million | 1.87 Million | -682 Thousand | -769 Thousand |
| Net cash flow / Change in cash | -553.26 Million | -174.44 Million | 875.53 Million | -4.79 Million | 44.01 Million | 35.33 Million |
| Free Cash Flow | 378.84 Million | 253.32 Million | 1.75 Billion | 404.62 Million | 363.11 Million | 214.33 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 43.02 Million | 69.54 Million | 352.13 Million | 130.79 Million | 456.54 Million | 129.16 Million |
| Depreciation & Amortization | 485.79 Million | 357.79 Million | 922.7 Million | 577.36 Million | 963.03 Million | 456.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 354.14 Million | 376.42 Million | - | -222.53 Million | -472.2 Million |
| Other non-cash items | 169.96 Million | -321.05 Million | 177.19 Million | 291.7 Million | -212.61 Million | 407.92 Million |
| Investing Cash Flow | -283.65 Million | -1.28 Billion | -1.84 Billion | -557.77 Million | -835.63 Million | -582.59 Million |
| Investments in PPE | -501 Million | -743.72 Million | -1.08 Billion | -337.73 Million | -731.1 Million | -468.41 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 20.55 Million | - |
| Other Investing Activities | 217.34 Million | -541.29 Million | -774.61 Million | -220.04 Million | -125.07 Million | -114.18 Million |
| Financing Cash Flow | -483.15 Million | -128.73 Million | -212.07 Million | -83.33 Million | -307.81 Million | -81.2 Million |
| Debt repayment | -483.15 Million | - | -199.91 Million | -83.33 Million | -949.68 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -128.73 Million | - | -83.33 Million | 641.87 Million | -81.2 Million |
| Accounts receivables | - | 118.16 Million | 118.16 Million | - | 2.28 Million | 2.28 Million |
| Accounts payables | - | - | - | - | 249.66 Million | - |
| Inventory | - | 253.26 Million | 253.26 Million | - | -224.82 Million | -224.82 Million |
| Other working capital | - | -17.28 Million | -17.28 Million | - | -249.66 Million | -249.66 Million |
| Cash at beginning of period | 302.73 Million | 1.13 Billion | 855.99 Million | 855.99 Million | 1.03 Billion | 1.01 Billion |
| Cash at end of period | 307.22 Million | 1.13 Billion | 302.73 Million | 1.13 Billion | 855.99 Million | 855.99 Million |
| Capital Expenditure | -501 Million | -743.72 Million | -1.08 Billion | -337.73 Million | -731.1 Million | -468.41 Million |
| Effect of forex changes on cash | 72.52 Million | 124.91 Million | 41.29 Million | -83.61 Million | -15.42 Million | -17.49 Million |
| Net cash flow / Change in cash | 4.49 Million | - | -553.26 Million | 275.14 Million | -174.44 Million | -160.36 Million |
| Free Cash Flow | 197.77 Million | -283.29 Million | 378.84 Million | 662.13 Million | 253.32 Million | 52.52 Million |
ADANIENT
SAPX
SEDA-WT
300661
075180
AIMS